BioXcel Therapeutics Inc.

NASDAQ: BTAI · Real-Time Price · USD
5.47
0.72 (15.16%)
At close: Aug 15, 2025, 3:59 PM
6.07
10.98%
After-hours: Aug 15, 2025, 07:58 PM EDT

BioXcel Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
17.43M 31.01M 29.85M 40.39M 56.27M 74.14M 65.22M 89.96M 127.55M 165.52M 193.72M 232.31M 233.45M 200.44M 232.97M 252.91M 273.06M 194.01M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a 87K 87K 87K 87K 87K 87K 87K 87K 925K 925K 925K 925K 965K 3.93M 1.75M 1.63M 633K
Receivables
17K n/a 131K 3K 812K 378K 71K 735K 431K 283K 248K n/a n/a n/a n/a n/a n/a n/a
Inventory
506K 642K 679K 1.52M 2.68M 2.44M 1.99M 2.02M 1.93M 1.95M 1.99M 1.41M 1.4M 682K n/a n/a n/a n/a
Other Current Assets
7.29M 1.39M 1.44M 1.4M 1.64M 1.86M 2.08M 2.17M 4.64M 5.01M 3.84M 2.43M 1.69M 1.48M 956K n/a 3.6M 2.77M
Total Current Assets
25.24M 37.78M 37.39M 47.79M 64.18M 80.92M 72.14M 98.74M 138.24M 177.27M 202.87M 241.66M 244.92M 207.56M 232.97M 256.93M 276.66M 196.78M
Property-Plant & Equipment
546K 702K 857K 1.01M 1.17M 1.32M 1.47M 1.62M 1.77M 1.91M 2.06M 2.23M 2.39M 2.52M 2.54M 2.65M 2.82M 2.97M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
546K 789K 944K 1.1M 1.25M 1.41M 1.56M 1.71M 1.86M 2.83M 2.98M 3.16M 3.31M 3.48M 6.47M 4.4M 4.45M 3.61M
Total Assets
25.79M 38.57M 38.34M 48.89M 65.44M 82.32M 73.7M 100.45M 140.1M 180.1M 205.85M 244.82M 248.24M 211.04M 239.44M 261.33M 281.11M 200.39M
Account Payables
16.69M 15.45M 15.99M 14.89M 13.26M 17.22M 13.65M 10.67M 11.2M 7.74M 10.23M 5.87M 6.02M 5.07M 4.68M 3.44M 2.5M 5.31M
Deferred Revenue
n/a n/a n/a n/a n/a 85K 116K -339K 23.09M n/a n/a n/a n/a n/a -293K 199K -281K -275K
Short-Term Debt
11.47M 5.61M n/a n/a n/a 353K 346K 339K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
5.06M 173K 142K 10.19M 2.44M 12.48M 12.53M 602K 4.16M 2.81M 6.46M 4.83M 10.07M 8.41M 7.43M 154K 7.22M 4.76M
Total Current Liabilities
33.38M 25.55M 22.23M 25.56M 27.29M 31.48M 27.27M 39.41M 34.74M 28.76M 32.9M 23.38M 20M 16M 16.67M 14.6M 12.44M 12.32M
Long-Term Debt
97.47M 99.92M 102.51M 104.44M 103.01M 101.63M 100.6M 99.09M 97.46M 95.77M 93.84M 91.69M 62.02M 1.03M 1.1M 1.18M 1.25M 1.33M
Other Long-Term Liabilities
2.61M 3.27M 6.63M 4.37M 9.19M 21.22M 1.91M 2.03M 1.41M 1.87M 1.56M 1.89M 1M -1.03M -1.1M -1.18M -1.25M -1.33M
Total Long-Term Liabilities
100.08M 103.19M 109.21M 108.97M 112.45M 123.2M 102.94M 101.65M 99.49M 98.34M 96.18M 94.45M 63.98M 1.03M 1.1M 1.18M 1.25M 1.33M
Total Liabilities
133.46M 128.74M 131.44M 134.53M 139.74M 154.69M 130.21M 141.06M 134.23M 127.1M 129.08M 117.83M 83.97M 17.02M 17.77M 15.78M 13.7M 13.65M
Total Debt
108.69M 105.91M 102.95M 104.97M 103.26M 102.34M 101.38M 99.62M 97.8M 96.09M 94.16M 92.88M 62.33M 1.33M 1.4M 1.47M 1.25M 1.33M
Common Stock
60K 59K 49K 42K 40K 34K 30K 29K 29K 29K 28K 28K 28K 28K 28K 28K 28K 25K
Retained Earnings
-676.64M -657.45M -650.2M -639.34M -625.69M -617.39M -590.6M -568.34M -517.86M -464.34M -411.55M -356.74M -314.93M -277.26M -245.79M -219.66M -192.85M -165.23M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 0.00 0.00 0.00 n/a n/a 0.00 -0.00 n/a
Shareholders Equity
-107.67M -90.17M -93.1M -85.63M -74.3M -72.36M -56.51M -40.61M 5.86M 53.01M 76.78M 126.99M 164.26M 194.02M 221.67M 245.56M 267.41M 186.74M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a